https://www.selleckchem.com/products/zanubrutini-bgb-3111.html Throughout the COVID-19 pandemic, drive-through testing centers have proven more effective in expanding testing capacity than traditional clinic models. If this infrastructure is repurposed and expanded for a large-scale vaccination campaign, it can facilitate throughput, reduce resource use, and overcome barriers associated with vaccine adoption and distribution. Vaccine hesitancy is a potential threat to global public health. Since there is an unprecedented global effort to develop a vaccine against the COVID-19 pandemic, much less is known about its acceptance in the community. Understanding key determinants that influence the preferences and demands of a future vaccine by the community may help to develop strategies for improving the global vaccination program. The aim of this study was to assess the prevalence of the acceptance of COVID-19 vaccine and their determinants among people in Saudi Arabia. A web-based, cross-sectional study was conducted using snowball sampling strategy under a highly restricted environment. A bilingual, self-administered anonymous questionnaire was designed and sent tothestudy participants through social media plat-forms and email. Study participants were recruited across the country, including the four major cities(Riyadh, Dammam, Jeddah, and Abha)in Saudi Arabia. Key determinants that predict vaccine acceptance among respondents w the global vaccination program to tackle future pandemics. Targeted health education interventions are needed to increase the uptake of the future COVID-19 vaccine. In addition to its respiratory impact of SARS-CoV2, skin lesions of probable vascular origin have been described. This study intends to quantify the incidence of acro-ischemic lesions in COVID-19 infected adult subjects in our population, describing clinical patterns and associated findings. All adult confirmed cases of COVID-19 infection who presented with acro-ischemic lesions an